发明名称 METHOD FOR IN VITRO DOWN-REGULATION OF AMYLOID PRECURSOR PROTEIN
摘要 Disclosed are novel methods for combatting diseases characterized by deposition of amyloid. The methods generally rely on immunization against amyloid precursor protein (APP) or beta amyloid (A&bgr;). Immunization is preferably effected by administration of analogues of autologous APP or A&bgr;, said analogues being capable of inducing antibody production against the autologous amyloidogenic polypeptides. Especially preferred as an immunogen is autologous A&bgr;, which has been modified by introduction of one single or a few foreign, immunodominant and promiscuous T-cell epitopes. Also disclosed are nucleic acid vaccination against APP or A&bgr; and vaccination using live vaccines as well as methods and means useful for the vaccination. Such methods and means include methods for the preparation of analogues and pharmaceutical formulations, as well as nucleic acid fragments, vectors, transformed cells, polypeptides and pharmaceutical formulations.
申请公布号 EA007533(B1) 申请公布日期 2006.10.27
申请号 EA20040000332 申请日期 2002.08.20
申请人 PHARMEXA A/S 发明人 RASMUSSEN PETER, BIRK;JENSEN MARTIN, ROLAND;NIELSEN KLAUS, GREGORIUS;KOEFOED PETER;DEGAN FLORENCE, DAL
分类号 A61K39/00;A61K39/10;A61K39/385;A61P25/28;C07K14/47 主分类号 A61K39/00
代理机构 代理人
主权项
地址